According to Boehringer Ingelheim's 2023 annual report, the drug's strong performance was attributed to continued strong momentum in indication growth, with European and US regulatory approvals for the treatment of chronic kidney disease and pediatric type 2 diabetes
DHM inhibited the SPHK1/mTOR pathway, reducing ferroptosis and CIRI in MCAO/R rats
Important safety information: Both Mounjaro (tirzepatide) and Wegovy (semaglutide) are prescription-only medications
Expert consensus on oral minoxidil for hair disorders
Logan, a 28-year-old teacher from Iowa, told Hunterbrook Media he had been denied access to GLP-1 drugs by insurance four times even though he had been prescribed Wegovy by a doctor
Article 5 mins 3 Ways to Manage Business Interruption During Uncertain Times With increasing global uncertainty, businesses should focus on emerging threats and decide how to best address them